Table 2.
Pre-treatment and 6 months findings of the patients treated with HA-CS and HA
| HA-CS | HA | HA-CS vs HA | |||||
|---|---|---|---|---|---|---|---|
|
| |||||||
| Initial visit | 6 months | p value | Initial visit | 6 months | p value | p value | |
| VAS | 8.2 ± 2.09 | 4.9 ± 2.08 | 0.000 | 8 ± 2.88 | 4.5 ± 2.52 | 0.000 | 0.761 |
| Frequency: mean ± SD | 15.1 ± 7.03 | 12 ± 4.51 | 0.002 | 14.8 ± 6.47 | 11.8 ± 4.52 | 0.010 | 0.698 |
| Nocturia: mean ± SD | 3.1 ± 2.40 | 1.4 ± 1.28 | 0.001 | 3.1 ± 2.55 | 1.3 ± 1.32 | 0.002 | 0.861 |
| ICSI | 15.2 ± 3.57 | 11.4 ± 4.46 | 0.001 | 15.2 ± 3.95 | 11.1 ± 4.77 | 0.003 | 0.891 |
| ICPI | 13.2 ± 2.52 | 8.4 ± 4.45 | 0.000 | 13.3 ± 2.70 | 8.9 ± 4.35 | 0.000 | 0.665 |
| Cystometric capacity (mL), mean ± SD | 301.6 ± 121.92 | 322.5 ± 126.78 | 0.130 | 286.2 ± 127.24 | 322.4 ± 119.12 | 0.135 | 0.973 |
| Voided volume (mL), mean ± SD | 154.6 ± 94.17 | 173.7 ± 86.10 | 0.059 | 151 ± 90.59 | 164.9 ±80.22 | 0.555 | 0.473 |
Results of the 2 different therapies compared in the last column. HA: hyaluronic acid; CS: chondroitin sulphate; VAS: visual analog pain scale; ICSI: interstitial cystitis symptom index; ICPI: interstitial cystitis problem index; PST: potassium sensitivity test; SD: standard deviation; SD: standard deviation.